News
NEW YORK – GSK will roll out its anti-PD-1 therapy Jemperli (dostarlimab) for certain endometrial cancer patients and its PARP inhibitor Zejula (niraparib) for ovarian cancer patients in India.
7h
Medindia on MSNGuide to Endometrial Cancer Prevention: What Every Woman Needs to Know
Tailoring prevention to a person's metabolic profile, especially addressing insulin resistance and inflammation , shows ...
GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...
Here is our list of the 11 best cancer stocks to buy right now.
In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...
The cause of death for actress Loni Anderson has been confirmed less than three weeks after she died at age 79. Anderson died ...
Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...
Actress Loni Anderson's cause of death revealed to be metastatic uterine leiomyosarcoma, according to a death certificate obtained by TMZ.
The National Cancer Institute of the National Institutes of Health has awarded Dr. Anna Gottschlich, assistant professor of oncology in the Wayne State University School of Medicine and the Barbara ...
5d
TipRanks on MSNBioNTech’s Promising Phase III Study on Recurrent Endometrial Cancer
BioNTech SE, in collaboration with DualityBio Inc., is conducting a Phase III clinical study titled A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator’s Choice ...
Endometrial cancer is hard to detect. Here are some signs of endometrial cancer worth bringing to your doctor's attention, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results